A mantle cell lymphoma that affects the stomach. It may arise as a solitary mass or it may be a component of multifocal lymphomatous polyposis of the gastrointestinal tract. It usually has an aggressi...
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding gastric mantle cell lymphoma is largely due to its rarity, which restricts the scope of systematic clinical studies. Additionally, the aggressive nature of the disease may lead to variable clinical presentations, complicating comprehensive characterization. As a result, there is an ongoing need for research to better understand this condition and improve patient outcomes.
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
There are several orphan drugs approved for gastric mantle cell lymphoma, including acalabrutinib, ibrutinib, and lenalidomide, among others. Additionally, there are multiple drugs in development aimed at treating this condition. Currently, there are four active clinical trials that may provide opportunities for participation. For more information on these trials, you can visit ClinicalTrials.gov and search for 'gastric mantle cell lymphoma'.
Actionable guidance for navigating care for gastric mantle cell lymphoma
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding gastric mantle cell lymphoma is largely due to its rarity, which restricts the scope of systematic clinical studies. Additionally, the aggressive nature of the disease may lead to variable clinical presentations, complicating comprehensive characterization. As a result, there is an ongoing need for research to better understand this condition and improve patient outcomes.
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
There are several orphan drugs approved for gastric mantle cell lymphoma, including acalabrutinib, ibrutinib, and lenalidomide, among others. Additionally, there are multiple drugs in development aimed at treating this condition. Currently, there are four active clinical trials that may provide opportunities for participation. For more information on these trials, you can visit ClinicalTrials.gov and search for 'gastric mantle cell lymphoma'.
Actionable guidance for navigating care for gastric mantle cell lymphoma
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding gastric mantle cell lymphoma is largely due to its rarity, which restricts the scope of systematic clinical studies. Additionally, the aggressive nature of the disease may lead to variable clinical presentations, complicating comprehensive characterization. As a result, there is an ongoing need for research to better understand this condition and improve patient outcomes.
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
There are several orphan drugs approved for gastric mantle cell lymphoma, including acalabrutinib, ibrutinib, and lenalidomide, among others. Additionally, there are multiple drugs in development aimed at treating this condition. Currently, there are four active clinical trials that may provide opportunities for participation. For more information on these trials, you can visit ClinicalTrials.gov and search for 'gastric mantle cell lymphoma'.
Actionable guidance for navigating care for gastric mantle cell lymphoma
To navigate your care effectively, seek a hematologist or oncologist with expertise in lymphoma, particularly those familiar with gastric mantle cell lymphoma. Consider exploring clinical trial opportunities, as participation may provide access to cutting-edge therapies. You can find clinical trials at ClinicalTrials.gov. Additionally, while there are currently no patient organizations specifically for gastric mantle cell lymphoma, resources like the National Organization for Rare Disorders (NORD) at rarediseases.org may offer support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 5 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.